Gayer Charles K

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Gayer Charles K's trades of BioCryst Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
299.61
Quantity 35,838 -18.5%
Value US$2,591,252
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-15 2024-05-13
B Purchase
35,838 -18.5%
299.61
US$2,591,252 		35,838 -18.5% 299.61 US$2,591,252
2022-12-19 2022-12-15
PlS Planned sale
49,672 +11.9%
211.15
US$4,589,866 		49,672 +11.9% 211.15 US$4,589,866